Question

Instructions The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y312 Accounts payable (merchandise creditors) $425,140.00 $404,540.00 13 Accrued expenses payable (operating expenses) 42,020.0E. There was a $198,010 credit to Retained Earnings for net income. F. There was a $95,680 debit to Retained Earnings for casLabels and Amount Descriptions Labels and Amount Descriptions Cash paid for dividends Cash paid for merchandise Cash paid forDecrease in accounts receivable Decrease in accrued expenses payable Decrease in inventories Depreciation For the Year EndedNet cash flow from operating activities Net cash flow used for operating activities Net cash flow from investing activities NStatement of Cash Flows Prepare a statement of cash flows, using the indirect method of presenting cash flows from operating13 Cash flows from investing activities: 19 Cash flows from financing activities:24 Cash at the beginning of the year 25 Cash at the end of the year

0 0
Add a comment Improve this question Transcribed image text
Answer #1

$198,010 Livers Inc. Statement of Cash Flows For the Year Ended December 31, 20Y3 Cash flows from operating activities Net InCash flows from investing activities: Cash received from sale of investments Cash paid for purchase of land Cash paid for purExplanation: Depreciation = ($166,970 – $148,000) = $18,970 Gain on sale of investments = ($279,880 – $239,300) = $40.580 Inc

Add a comment
Know the answer?
Add Answer to:
Instructions The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown...
Your Answer:

Post as a guest

Your Name:

What's your source?

Earn Coins

Coins can be redeemed for fabulous gifts.

Not the answer you're looking for? Ask your own homework help question. Our experts will answer your question WITHIN MINUTES for Free.
Similar Homework Help Questions
  • The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows:...

    The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows: Dec. 31, 20Y2 Dec. 31, 20Y3 Assets 2 $625,650.00 $586,340.00 3 Cash Accounts receivable (net) 208,030.00 228,170.00 4 5 Inventories 641,480.00 617,130.00 0.00 240,290.00 6 Investments 7 Land 328,170.00 0.00 8 Equipment 552,300.00 706,070.00 (147,010.00) 9 Accumulated depreciation-equipment (165,580.00) $2,363,960.00 $2,057,080.00 10 Total assets Liabilities and Stockholders' Equity 11 1. $424,300.00 $404,860.00 12 Accounts payable (merchandise creditors) 13 Accrued expenses payable (operating expenses) 41,850.00...

  • he comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as...

    he comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets Cash $270,970 $250,900 Accounts receivable (net) 98,160 90,110 Inventories 277,110 266,820 Investments 0 103,360 Land 142,130 0 Equipment 305,730 235,880 Accumulated depreciation—equipment (71,580) (63,610) Total assets $1,022,520 $883,460 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $185,080 $174,040 Accrued expenses payable (operating expenses) 18,410 22,970 Dividends payable 10,230 7,950 Common stock, $10 par 55,220 43,290 Paid-in...

  • The comparative balance sheet of Navaria Inc. for December 31, 20Y3 and 20Y2, is shown as...

    The comparative balance sheet of Navaria Inc. for December 31, 20Y3 and 20Y2, is shown as follows: 1 Dec. 31, 20Y3 Dec. 31, 20Y2 2 Assets 3 Cash $626,640.00 $585,760.00 4 Accounts receivable (net) 226,900.00 208,390.00 5 Inventories 641,350.00 616,130.00 6 Investments 0.00 239,300.00 7 Land 328,730.00 0.00 8 Equipment 705,940.00 553,530.00 9 Accumulated depreciation-equipment (166,970.00) (148,000.00) 10 Total assets $2,362,590.00 $2,055,110.00 11 Liabilities and Stockholders’ Equity 12 Accounts payable $425,140.00 $404,540.00 13 Accrued expenses payable 42,020.00 52,750.00 14 Dividends...

  • Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3...

    Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets Cash $253,630 $237,840 Accounts receivable (net) 91,880 85,420 Inventories 259,370 252,910 Investments 0 97,980 Land 133,030 0 Equipment 286,170 223,600 Accumulated depreciation—equipment (67,000) (60,300) Total assets $957,080 $837,450 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $173,230 $164,980 Accrued expenses payable (operating expenses) 17,230 21,770 Dividends payable 9,570 7,540 Common stock,...

  • The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows:...

    The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows: 1 Dec. 31, 20Y3 Dec. 31, 20Y2 2 Assets 3 Cash $625,650.00 $586,340.00 4 Accounts receivable (net) 228,170.00 208,030.00 5 Inventories 641,480.00 617,130.00 6 Investments 0.00 240,290.00 7 Land 328,170.00 0.00 8 Equipment 706,070.00 552,300.00 9 Accumulated depreciation-equipment (165,580.00) (147,010.00) 10 Total assets $2,363,960.00 $2,057,080.00 11 Liabilities and Stockholders’ Equity 12 Accounts payable (merchandise creditors) $424,300.00 $404,860.00 13 Accrued expenses payable (operating expenses) 41,850.00...

  • Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is...

    Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets Cash $244,600 $230,160 Accounts receivable (net) 88,610 82,660 Inventories 250,140 244,740 Investments 0 94,820 Land 128,300 0 Equipment 275,980 216,380 Accumulated depreciation—equipment (64,610) (58,350) Total assets $923,020 $810,410 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $167,070 $159,650 Accrued expenses payable (operating expenses) 16,610 21,070 Dividends payable 9,230 7,290 Common stock,...

  • Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3...

    Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets Cash $261,120 $243,460 Accounts receivable (net) 94,590 87,440 Inventories 267,040 258,890 Investments 0 100,300 Land 136,970 0 Equipment 294,620 228,890 Accumulated depreciation—equipment (68,980) (61,720) Total assets $985,360 $857,260 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $178,350 $168,880 Accrued expenses payable (operating expenses) 17,740 22,290 Dividends payable 9,850 7,720 Common stock,...

  • Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3...

    Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets Cash $261,120 $243,460 Accounts receivable (net) 94,590 87,440 Inventories 267,040 258,890 Investments 0 100,300 Land 136,970 0 Equipment 294,620 228,890 Accumulated depreciation—equipment (68,980) (61,720) Total assets $985,360 $857,260 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $178,350 $168,880 Accrued expenses payable (operating expenses) 17,740 22,290 Dividends payable 9,850 7,720 Common stock,...

  • Instructions The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown...

    Instructions The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec 31, 2093 Dec 31, 2092 Assets Cash $585.190.00 $626,100.00 228,630.00 Accounts receivable (net) 208.060.00 Inventories 641,030.00 617,620.00 Investments 0.00 239.850.00 Land 0.00 528.160.00 705.110.00 Equipment 1166.940.00) Accumulated depreciation-equipment Total assets Liabilities and Stockholders' Equity 553.850.00 (147,700.00) 52.056.850.00 $2.382.190.00 Check My Work Assignment Score: 49.13% TEZOVUZLUUMUUUU $423,690.00 case Labilities and Stockholders' Equity 12 Accounts payable (merchandise creditors) 13 Accrued expenses payable (operating...

  • Statement of Cash Flows-Indirect Method The comparative balance sheet of Livers Inc. for December 31, 2013...

    Statement of Cash Flows-Indirect Method The comparative balance sheet of Livers Inc. for December 31, 2013 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 2012 Assets Cash Accounts receivable (net) $251,660 91,170 257,350 $235,180 84,470 250,070 96,890 Inventories Investments 0 Land 221,100 Equipment Accumulated depreciation equipment 132,000 283,950 (66,480) $949,650 (59,620) $828,090 Total assets Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) Accrued expenses payable (operating expenses) $171,890 17,090 9,500 $163,130 21,530 7,450 40,580 Dividends payable Common...

ADVERTISEMENT
Free Homework Help App
Download From Google Play
Scan Your Homework
to Get Instant Free Answers
Need Online Homework Help?
Ask a Question
Get Answers For Free
Most questions answered within 3 hours.
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT